PMC:7574920 / 5215-5916
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T24 | 535-538 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T25 | 641-644 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T26 | 682-689 | Body_part | denotes | genomes | http://purl.org/sig/ont/fma/fma84116 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T35 | 287-295 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T36 | 524-532 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T59 | 104-105 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T60 | 239-243 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T61 | 474-478 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T12 | 318-326 | Chemical | denotes | reagents | http://purl.obolibrary.org/obo/CHEBI_33893 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 92 | 524-534 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 93 | 287-295 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 435-444 | http://purl.obolibrary.org/obo/GO_0006810 | denotes | transport |
| T30 | 494-496 | http://purl.obolibrary.org/obo/GO_0001171 | denotes | RT |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T35 | 0-251 | Sentence | denotes | This procedure includes several steps that require sample handling; therefore, the detection process in a clinical diagnostic laboratory takes about 3 to 24 hours or more, depending on the number of samples and process optimization of the test center. |
| T36 | 252-445 | Sentence | denotes | In addition, in the context of the COVID-19 pandemic, many of the reagents required are only slowly being replenished due to insufficient production capacity or lack of international transport. |
| T37 | 446-570 | Sentence | denotes | Therefore, increasing daily test capacities for RT-qPCR–based diagnostics for SARS-CoV-2 RNA detection is currently limited. |
| T38 | 571-701 | Sentence | denotes | To accelerate and optimize such diagnostics, new scalable methods for RNA isolation and the detection of viral genomes are needed. |